Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PostbiotiX Comfort is a postbiotic food supplement developed by Postbiotica for the management of intestinal disorders and gastrointestinal discomfort. The product is formulated using PBTech® technology, which involves the controlled fermentation of fructooligosaccharides (FOS) by the strain *Lactobacillus paracasei* CNCM I-5220 to produce a complex of bioactive metabolites (postbiotics). It also contains lemon balm (*Melissa officinalis*) extract, which is included to support regular gastrointestinal motility and facilitate the elimination of intestinal gas. Designed to restore microbiota balance and support the intestinal barrier, PostbiotiX Comfort is intended for oral administration to relieve symptoms such as abdominal bloating and irregularity. It is characterized as being gluten-free and lactose-free.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PostbiotiX Comfort.